X0306 4 2021-05-07 0 0001699382 PMV Pharmaceuticals, Inc. PMVP 0001825216 Alland Leila C/O PMV PHARMACEUTICALS, INC. 8 CLARKE DRIVE, SUITE 3 CRANBURY NJ 08512 0 1 0 0 Chief Medical Officer Common Stock 2021-05-07 4 M 0 4000 3.90 A 4000 D Common Stock 2021-05-07 4 S 0 3842 34.80 D 158 D Common Stock 2021-05-07 4 S 0 158 35.4891 D 0 D Employee Stock Option (right to buy) 3.90 2021-05-07 4 M 0 4000 0.00 D 2030-02-04 Common Stock 4000 369850 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.30 to $35.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.47 to $35.50, inclusive. One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter. /s/ Winston Kung, by power of attorney 2021-05-10